Stay updated on Safety of Selonsertib, Firsocostat, & Cilofexor in NASH Clinical Trial
Sign up to get notified when there's something new on the Safety of Selonsertib, Firsocostat, & Cilofexor in NASH Clinical Trial page.

Latest updates to the Safety of Selonsertib, Firsocostat, & Cilofexor in NASH Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page's revision label changed from v3.5.3 to v3.5.4, indicating a minor version update to the page's documentation/history.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedUpdates the ClinicalTrials.gov page footer from **Revision: v3.5.2** to **Revision: v3.5.3**.SummaryDifference0.0%

- Check46 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check60 days agoChange Detected- Removed the topic 'Non-alcoholic fatty liver disease' and the related topic 'MedlinePlus Genetics' from the page.SummaryDifference0.1%

- Check75 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0 in the page header.SummaryDifference0.0%

- Check82 days agoChange DetectedRevision: v3.4.3 is now displayed, replacing the previous Revision: v3.4.2.SummaryDifference0.0%

Stay in the know with updates to Safety of Selonsertib, Firsocostat, & Cilofexor in NASH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Selonsertib, Firsocostat, & Cilofexor in NASH Clinical Trial page.